24-Apr-2024
Cue Health Announces CFO Transition and New Appointment
TipRanks (Wed, 24-Apr 9:12 AM ET)
Cue Health Announces Strategic Actions to Position Company for Next Stage
Business Wire (Wed, 20-Mar 5:21 PM ET)
Cue Health Reports Fourth Quarter 2023 Financial Results
Business Wire (Wed, 13-Mar 4:01 PM ET)
Cue Health to Announce Fourth Quarter and Full Year 2023 Financial Results
Business Wire (Wed, 28-Feb 4:01 PM ET)
Cue Health Announces Appointment of Rishi Reddy to Board of Directors
Business Wire (Fri, 16-Feb 5:00 PM ET)
Business Wire (Wed, 31-Jan 4:01 PM ET)
Cue Health Inc is a health technology company. It puts consumers in control of health information and places diagnostic information at the center of care. It enables people to manage their health through real-time, actionable and connected health data. Further, it offers individuals, enterprises, government agencies, and healthcare providers access to lab-quality diagnostic testing at home, at work, or at the point of care, all in a device that fits in the palm of hand. Its Cue Integrated Care Platform consists of multiple hardware, software, and diagnostic components and has been engineered so that it can be directly integrated into existing workflows and on-demand services, such as telemedicine, e-Rx services, and EMR systems.
Cue Health trades on the NASDAQ stock market under the symbol HLTH.
As of April 24, 2024, HLTH stock price declined to $0.15 with 222,181 million shares trading.
HLTH has a beta of 2.09, meaning it tends to be more sensitive to market movements. HLTH has a correlation of 0.05 to the broad based SPY ETF.
HLTH has a market cap of $23.23 million. This is considered a Sub-Micro Cap stock.
Last quarter Cue Health reported $19 million in Revenue and -$.32 earnings per share. This beat revenue expectation by $1 million and exceeded earnings estimates by $.12.
The top ETF exchange traded funds that HLTH belongs to (by Net Assets): VTI, VXF, IWC, ONEQ.
HLTH has underperformed the market in the last year with a price return of -85.1% while the SPY ETF gained +24.1%. HLTH has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -35.1% and -15.4%, respectively, while the SPY returned +4.5% and -1.7%, respectively.
HLTH support price is $.14 and resistance is $.16 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HLTH stock will trade within this expected range on the day.